top | item 31179920

(no title)

xyzzy21 | 3 years ago

This is a legal problem - allowing broadcast advertisements to the general public for pharma products is where the problem started. Before that, pharma had to advertise in targeting media directly addressing the medical profession only, e.g. JAMA, NEJM, various trade magazines, etc.

That's how this should be fixed - return to those limits. In an online environment that would mean limiting ads to doctors et al. on sites that require password and professional identification/validation. Otherwise information on drugs et al. should be presented only neutrally and scientifically to the broader public - marketing should be banned from the process.

discuss

order

No comments yet.